NorthWest Biotherapeutics Inc (NWBO)

[john1045]

If NWBO comes out with peer reviewed publication Top Line PR this will go viral. Notice the language from the comments from the article below are in sync with what NWBO has publically stated with regards publication and peer review IMHO. NWBO needs to get this to patients ASAP!

Dr David Jenkinson, Chief Scientific Officer at The Brain Tumour Charity, said:

“The data presented are really promising and we now very eagerly await publication of the final results following peer review.

“Glioblastomas remain the most common and most aggressive form of brain cancer and with so few treatments available, thousands affected by the disease in the UK each year are in urgent need of new options.

“It is fantastic to see that many years of research and innovation may now be on the cusp of delivering a long-awaited new therapy for those living with glioblastomas.

“We need to wait for these results to be independently validated, but we are now really hopeful that DCVax-L may represent the first new treatment able to offer life-extension to people living with a glioblastoma in over fifteen years.”

Professor Michael Jenkinson, Professor of Neurosurgery at the University of Liverpool and Chair of the NCRI Brain Group, said:

“The results of the dendritic cell vaccine trial hold real promise for patients with glioblastoma. This is the first drug trial since the introduction of temozolomide that has shown a meaningful improvement in survival, and that could represent the new standard of care for our patients.“